Abstract
The authors describe a method for the detection and determination of human liver cancer cells in blood. The cytosensing system consists of a microfabricated chip-based electrochemical aptasensor that contains multifunctional hybrid electrochemical nanoprobes and an indium tin oxide (ITO) electrode array interface functionalized with cell-targeting aptamer and gold nanoparticles (AuNPs). The thiolated cell targeting aptamer (referred to as TLS11a) was immobilized on the ITO electrode/AuNPs for specific adhesion of hepatocellular carcinoma cells (HepG2). The hybrid nanoprobe system consists of hydroquinone (HQ) as an electrochemical probe, horseradish peroxidase (HRP), and an aptamer/hemin/G-quadruplex aggregate that was immobilized on gold/palladium-functionalized ZnO nanorods (ZnO@Au-Pd). The nanoprobes are capable of amplifying the voltammetric signal and capturing the target cells. Best operated at around −90 mV (vs Ag/AgCl), the electrode has a linear response that covers the 10^2 to 10^7 HepG2 cells per mL concentration range, with a 10 cell per mL detection limit. Captured cells may be released from the electrode via electrochemical desorption to break the Au-S bonds.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
